Literature DB >> 1653555

Effects of tumor necrosis factor alpha on replication of varicella-zoster virus.

M Ito1, T Nakano, T Kamiya, K Kitamura, T Ihara, H Kamiya, M Sakurai.   

Abstract

Replication of varicella-zoster virus (VZV) and expression of VZV nuclear antigen are inhibited in human embryonic lung fibroblast (HEL) cells pretreated with recombinant tumor necrosis factor (TNF) alpha for 24 h. This antiviral activity is completely blocked by the addition of monoclonal antibodies against TNF. TNF acts synergistically with interferons alpha and gamma. When TNF is added to HEL cells after VZV adsorption, virus replication is still inhibited. When VZV-infected HEL cells are co-cultured with HEL cells which have been pretreated with TNF or grown in the presence of TNF, spread of VZV from VZV-infected HEL cells to uninfected cells is unaffected. No interferon is detected in the supernatants or cell lysates of HEL cells cultured with TNF and antibodies to alpha-, beta- and gamma-interferon have no effect on the antiviral action of TNF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653555     DOI: 10.1016/0166-3542(91)90065-y

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  12 in total

1.  Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons.

Authors:  Christina N Como; Catherine M Pearce; Randall J Cohrs; Nicholas L Baird
Journal:  Virology       Date:  2018-07-04       Impact factor: 3.616

2.  The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature.

Authors:  Luisa Di Costanzo; Fabio Ayala; Matteo Megna; Francesca Gaudiello; Angela Patrì; Nicola Balato
Journal:  J Dermatol Case Rep       Date:  2013-03-30

3.  Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.

Authors:  Thomas E Morrison; Amy Mauser; Aloysius Klingelhutz; Shannon C Kenney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

Authors:  Nadia El Mjiyad; Sébastien Bontems; Geoffrey Gloire; Julie Horion; Patricia Vandevenne; Emmanuel Dejardin; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

5.  The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells.

Authors:  Celeste M Newby; Leah Sabin; Andrew Pekosz
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

6.  Infectious pulmonary complications in patients treated with anti-TNF-alpha monoclonal antibodies and soluble TNF receptor.

Authors:  Javier Carbone; Javier Perez-Rojas; Elizabeth Sarmiento
Journal:  Curr Infect Dis Rep       Date:  2009-05       Impact factor: 3.725

7.  VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs.

Authors:  David Schub; Gunter Assmann; Urban Sester; Martina Sester; Tina Schmidt
Journal:  Arthritis Res Ther       Date:  2018-11-09       Impact factor: 5.156

8.  Functional paralysis of human natural killer cells by alphaherpesviruses.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Tiffany Ann Russell; David Carl Tscharke; Jarrod John Kennedy; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2019-06-13       Impact factor: 6.823

9.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28

Review 10.  Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review.

Authors:  Byung-Soo Kim; Emanual Maverakis; Clarie Alexanian; Jenny Z Wang; Siba P Raychaudhuri
Journal:  J Cutan Med Surg       Date:  2020-04-02       Impact factor: 2.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.